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Background and Purpose: Exogenously administered fructose-l,6-bisphosphate reduces neuronal injury from hypoxic or ischemic brain insults. To test the hypothesis that fructose-l,6-bisphosphate prevents changes in intracellular calcium ([Ca 2+ ]j) and high-energy phosphate levels, we measured [Ca 2+ ]i, intracellular pH (pH>), and adenosine triphosphate in cultured rat cortical astrocytes and cortical brain slices during hypoxia.
Methods: The fluorescent indicators fura-2 and bis-carboxyethyl-carboxyfluorescein were used to simultaneously measure [Ca 2* ] ; and pH, with a fluorometer. Results: Exposure to hypoxia (95% N 2 ,5% CO 2 ) or 100 fiM sodium cyanide produced transient increases in |Ca 2+ ]i in astrocytes and sustained increases in [Ca 2+ ]i in brain slices. Adenosine triphosphate levels fell in slices exposed to hypoxia or cyanide. Fructose-l,6-bisphosphate (3.5 mM) blocked increases in [Ca 2+ ], and prevented depletion of adenosine triphosphate. Fructose-l,6-bisphosphate also partially prevented adenosine triphosphate depletion in brain slices incubated in glucose-free medium. Iodoacetate (a specific inhibitor of glycolysis) elevated [Ca 2+ L and partially prevented these actions of fructose-1,6-bisphosphate. Changes in pHj during hypoxia were not affected by fructose-l,6-bisphosphate.
Conclusions: Fructose-l,6-bisphosphate supports adenosine triphosphate production via stimulation of glycolysis and results in the maintenance of normal [Ca T reatment of animals with fructose-l,6-bisphosphate (FBP) reduces brain injury during global cerebral hypoxemia and ischemia, 1 insulin-induced hypoglycemia, 2 and hemorrhagic or cardiogenic shock.
3 -4 FBP also reduces damage to ischemic kidneys 5 and prevents adverse biochemical and histological changes in hypoxic myocardium. 6 The mechanism responsible for these protective effects of FBP is unclear. Although it is a phosphorylated sugar, FBP crosses the blood-brain barrier and enters neurons. 7 Possible intracellular actions of FBP during hypoxia or ischemia include 1) stimulation of carbohydrate metabolism through activation of phosphofructokinase 8 -9 ; 2) increased carbon flux through the pentose phosphate pathway (G. Gregory, J. Kelleher, T.Y. Chan, and P. Chan, unpublished observations); 3) direct glycolytic metabolism of FBP, with resulting ATP production 7 ; and 4) prevention of oxygen-derived free radical injury. 10 Another possible mechanism of protection, suggested to occur in the hypoxic myocardium 11 and in ethanol-exposed baby hamster kidney cells, 12 is prevention of the cytotoxic effects of increased intracellular Ca 2+ (Ca 2+ i).
We hypothesize that prevention of elevated [Ca 2+ ]| may be a plausible mechanism for the protective effect of FBP because elevations in [Ca 2+ ] i may play a central role in brain injuries caused by hypoxic or ischemic insults. 13 Causes of elevated [Ca 2+ ]i from these insults include membrane depolarization from failure of cellular energy production, excitatory neurotransmitter activation of Ca 2+ channels, 14 and release of Ca 2+ from
See Editorial Comment, p 1622 mitochondria or endoplasmic reticulum. 13 Based on previous studies suggesting direct metabolism of FBP or stimulation of glycolysis, prevention of energy failure seems one of the more plausible of these mechanisms. In addition, recent work has shown that 3.5 mM FBP prevents ATP depletion during hypoxia in astrocytes and increases their glutamate utilization. 15 We therefore wished to test the hypothesis that 3.5 mM FBP prevents elevation in [Ca 2 *], in hypoxic astrocytes and brain slices and prevents ATP depletion in brain slices.
Stimulation of carbohydrate metabolism by FBP may lower intracellular pH (pH,). Although low pH, may exacerbate injury from hypoxia, 16 recent evidence suggests that it may actually attenuate glutamate neurotoxicity in cortical neuronal cultures. 17 Therefore, we also measured pHj during hypoxia in FBP-treated brain slices and astrocytes.
Living cortical brain slices and cultured astrocytes were chosen as models to study cerebral hypoxia. Astrocytes were examined because they are known to be relatively tolerant of hypoxia compared with neurons and because FBP has recently been shown to prevent ATP depletion during hypoxia. 15 In both tissues we have measured [Ca 2+ ]j and pH; during hypoxia, simulated anoxia with cyanide, and blockade of glycolysis with iodoacetate (an inhibitor of the glycolytic enzyme glyceraldehyde phosphate dehydrogenase) and after glucose deprivation. These responses were compared with those seen when 3.5 mM FBP was present in the medium.
Materials and Methods

Brain Slice Preparation
Cortical brain slices were prepared from adult Sprague-Dawley rats. After rapid decapitation and dissection, 5x8-mm portions of cortex were placed in chilled (3-5°C) buffered salt solution (Earle's balanced salt solution with 5 mM glucose and 25 mM NaHCO 3 bubbled with 95% O 2 /5% CO 2 , pH 7.4). The brain pieces were then attached to a mounting block with cyanoacrylate cement, and 175-250-/im slices were prepared with a vibroslicer (Campden Instruments, Cambridge, England). The slices were transferred to room-temperature buffered salt solution and continuously bubbled with 95% O 2 /5% CO 2 . Fura-2 acetoxymethyl ester and 2',7'-bis-(2-carboxyethyl)-5-(and -6) carboxyfluorescein acetoxymethyl ester (BCECF) (Molecular Probes, Eugene, Ore.) were both added (from a 1-mM stock solution in dimethyl sulfoxide) to achieve final concentrations of 3-5 /xM. For both dyes, cell loading was found to be facilitated by allowing at least 1 hour of incubation. The slices were then transferred to petri dishes filled with buffered salt solution and washed for 5 minutes. The slices were mounted on a mesh baffle and fitted into a cuvette filled with O 2 /CO 2 equilibrated buffer. A cap, fitted with stainless steel inlet and outlet tubing to perfuse the slice with gas equilibrated buffer, was used to seal the cuvette. Fluorescence measurements were then made in a Hitachi Instruments F-2000 fluorometer (Tokyo) with samples positioned so that excitation light fell within the confines of the tissue. The cuvette holder and perfusing solution were both temperature controlled to 37±0.1°C.
Astrocyte Cultures
Primary cultures of cerebral astrocytes were prepared by the method of Booher and Sensenbrenner, 18 as modified by Yu et al, 19 using newborn Sprague-Dawley rats. Astrocytes were loaded with fluorescent dyes by incubation in buffered Earl's salt solution containing 3 liM fura-2 and 3 /xM BCECF for 45-180 minutes. The coverslips were then rinsed in a petri dish of buffered salt solution, and placed in a coverslip holder in a fluorometer cuvette. The cuvette and perfusion solutions were thermostatted to 37°C.
Calibration of Fura-2 and BCECF
An in vivo calibration protocol was used for each dye. Calibration for fura-2 was done essentially as described by Jensen and Chiu. 20 Slices were alternatively excited with 340-and 380-nm wavelengths, and fluorescence intensity at 510 nm was recorded every 1.0 second with a Hitachi F-2000 fluorometer. To reduce scattered excitation light, a 505-nm cut-off filter was placed over the emission port.
Measurement of pH ( was done simultaneously with that of Ca 2+ j by interleaving excitation at wavelengths of 440 and 495 nm with those for fura-2. Emission intensity for BCECF was recorded every 1.0 second at 530 nm. Excitation at 495 nm (instead of the usual 500 nm) was used with BCECF, as this greatly reduced the intensity of scattered light detected at 530 nm and improved sensitivity to pH changes. Calibration of BCECF was done by two methods. First, equilibration of intracellular and extracellular hydrogen ion concentrations was achieved by application of the K + -H + exchanger nigericin. At the end of some of the studies, the cells were perfused with a high-K + Earle's solution containing 100 mM KC1 and 10 mM nigericin. The pH| was calculated from the equation presented by Eisner et al. 21 The second method relied on exposing cells to Earl's solution equilibrated with different levels of Pco 2 . Because the effect of acute changes in Pco 2 on pH, in brain is known, 22 changing Pco 2 can be used as a method of pH calibration. Pco 2 values of 0, 40, and 80 mm Hg were used. The later method does not give an absolute value for pHj but rather a calibration for evaluating changes in pH|. The nigericin and Pco 2 methods were used in combination.
ATP Assays
ATP was extracted from brain slices by immersing individual slices in 0.5 ml 20-mM Tris buffer (pH 7.75) at 100°C for 10 minutes. After centrifugation, ATP was measured in 0.1 ml of the supernatant with a luciferin/ luciferase bioluminescent assay in a Model 2001 luminometer (Analytical Luminescence Laboratory, San Diego, Calif.). The sensitivity of the assay was approximately 1 pmol ATP, and ATP standards were used for calibration. Total protein was measured with a Coomassie blue assay 23 and results expressed as micromoles of ATP per milligram of protein.
Study Protocol
Before study, brain slices or astrocyte cultures were mounted in a fluorometer cuvette and incubated in oxygenated medium with or without 3.5 mM FBP for 10 minutes. The temperature was held at 37°C. Changes in medium composition, addition of cyanide or iodoacetate, were then made, and continuous measurements of [Ca 2+ ]j and pH, were made for 30-40 minutes. ATP levels were determined in brain slices treated identically except that they were not loaded with fluorescent dyes.
Statistical Methods
ANOVA was used to compare [Ca 2+ ] ; , ATP, and pH, values between different treatment groups. Student's t test, with a correction for multiple comparisons, was applied to examine the difference between a given treatment with and without FBP in the medium. Values are reported as mean±SD, and p< 0.05 was required for statistical significance.
Results
After 45 minutes of exposure to 3-5 /xM fura-2 and BCECF, both brain slices and astrocytes were loaded with sufficient dye to permit calcium and pH measurements. Dye leakage was sufficiently slow to allow measurements to be made for at least 1 hour after removal of tissue from the dye-loading bath. (Table 1) . After 10 minutes' exposure to cyanide, ATP declined to about 4 nmol/mg protein (4% of control). Hypoxia produced a similar fall in ATP levels (5±1.0 nmol ATP/mg protein). Iodoacetate treatment, which blocks glycolysis but leaves mitochondrial oxidative capacity intact, resulted in a 68 ±10% decrease in ATP levels in brain slices. Perfusion of tissue in glucose-free medium resulted in a 95% drop in ATP levels.
Intracellular pH declined by approximately 0.35 units in brain slices exposed to hypoxia or cyanide (Table 2) . In astrocytes, pH, fell by about the same amount. These changes were statistically significant (p<0.05). In contrast, iodoacetate produced alkalinization of pH, by about 0.15 units.
Effects ofFBP Treatment
Addition of 3.5 mM FBP greatly reduced the increase in Ca 2+ i that resulted from exposure to cyanide or hypoxia in both brain slices and astrocytes (Figure 4) . In Slices were incubated in artificial cerebrospinal fluid (CSF) with and without 3.5 mM fructose-l,6-biphosphate (FBP), with 100 fiM NaCN, 3.5 mM iodoacetate, or only artificial CSF medium with 5.5 mM glucose (Control).
'Statistically different from same treatment without FBP by two-tailed t test (p<0.05).
inhibition with iodoacetate treatment; with FBP the increase in [Ca 2+ ]i was only 36±12% of that seen without FBP. However, as shown in Figure 4 , when cyanide and iodoacetate were combined, [Ca 2+ ]i increased as in untreated slices.
FBP partially prevented depletion of ATP in brain slices exposed to hypoxia or cyanide (Table 1) . However, FBP did not prevent a fall in ATP in slices treated with iodoacetate. Similarly, FBP was ineffective in preventing ATP depletion when both iodoacetate and cyanide were present in the medium. In glucose-free medium, FBP treatment resulted in ATP levels that were approximately twice as high as without FBP (p<0.005).
The pHj declined by about 0.35 units (from 7.05 ±0.10 to 6.70±0.13, « = 10; /?<0.05) upon exposure of brain slices to hypoxia. Similar results were seen when FBP was present in the medium (pH changed from 7.05±0.13 to 6.74±0.10, n=10; difference from control not significant) and when cyanide was used instead of hypoxia. In astrocytes with no FBP present, hypoxia produced a drop in pH of 0.34 units; when 3.5 mM FBP was added, the drop in pH was 0.25 units (not significant). FBP treatment therefore did not change the degree of intracellular acidification caused by hypoxia or cyanide. (4) slices With FBP 7.05±0.07 (8) 6.72±0.10 (6) 7.22±0.08 (4) Astrocytes Without FBP 7.11±0.13 (6) 6.74±0.17 (6) With FBP 7.08±0.10
6.83 ±0.08 (6) Values are mean±SD. n, Number of brain slices or astroyctes (values in parentheses).
As pretreatment, 3.5 mM fructose-l,6-biphosphate (FBP) was administered 5-10 minutes before exposure to anoxia, cyanide, or iodoacetate. 
Discussion
Our results demonstrate that FBP prevents increased [Ca 2+ ]i in brain slices and astrocytes exposed to hypoxia, cyanide, or glucose-free medium. We have also shown that FBP prevents ATP depletion in brain slices during these insults. These findings may explain the protective effects of FBP in preventing brain injury during hypoglycemia, hypoxia, or circulatory failure previously noted by other investigators. 1 -3 Our conclusions are consistent with the hypothesis that FBP is protective by supporting energy metabolism and preventing ATP depletion in neuronal tissue. 7 Our results suggest, but do not prove, that stimulation of glycolysis during hypoxia may be the mechanism by which FBP promotes sustained ATP generation in the brain under anaerobic conditions. This conclusion is based on our findings that FBP resulted in significantly higher ATP levels in the absence of glucose and the fact that iodoacetate prevented FBP from sustaining ATP production in the presence of cyanide. It has been shown recently that FBP preserves ATP in astrocytes exposed to anoxic conditions. 15 In astrocytes, increased carbon flux through the pentose phosphate pathway may be responsible for ATP generation (G.A. Gregory, J.A. Kelleher, and P. Chan, unpublished data). This would also account for the inability of FBP to completely reverse the ATP reduction due to hypoxia.
Reduction in cellular ATP levels appears to correlate directly to elevations in [Ca 2+ ]i in both brain slices and astrocytes, but a causal relation has not been demonstrated. ATP depletion leading to cell membrane depolarization with subsequent Ca 2+ entry through voltagegated calcium channels has been suggested as a cause of elevation in [Ca 2+ ]i in anoxic or ischemic brain insults (reviewed in reference 13). Maintenance of low [Ca 2+ ]i and improved ATP levels during hypoxia or hypoglycemia in the presence of FBP is thus circumstantial evidence that cellular energy failure has not occurred. Elevations in [Ca 2+ ] j during hypoxic or ischemic insults may result from several other mechanisms: release of calcium from intracellular stores (e.g., mitochondria, endoplasmic reticula) and activation of ligand-gated calcium channels by excitatory neurotransmitters. 13 Cellular energy failure plays a direct role in the first two mechanisms. Because cyanide and iodoacetate together (i.e., when both glycolytic and oxidative ATP production is halted) caused elevations in Ca 2+ j even with FBP treatment, this is evidence that energy failure is most likely the cause for elevated [Ca 2+ ], in our preparations. We observed that while hypoxia produces a transient increase in [Ca 2+ ]j in astrocytes, it produces a sustained increase in brain slices. Although the mechanisms responsible for the restoration of normal [Ca 2+ ]i in anoxic astrocytes were not studied, it could be due to induction of increased anaerobic ATP production and subsequent recovery of the energy-requiring mechanisms that regulate cytosolic calcium concentrations. Astrocytes are tolerant of hypoxia, 15 but the contribution of [Ca 2+ ]j regulation to anoxic survival has not been studied.
In addition to preservation of ATP necessary for ionic regulation, it is possible that FBP may prevent increases in [Ca 2+ ]j by other mechanisms as well. These include chelation of Ca 2+ ; (although ionized calcium in the perfusion medium was unchanged by FBP) or blockade of calcium entry through effects on cell membrane calcium channels or at sites of intracellular sequestration. We have not explored either of these possibilities.
Changes in pHj during hypoxic insults were not affected by FBP treatment; thus, buffering of hypoxiainduced changes in pH; by FBP seems an unlikely mechanism for the protective effects of FBP. It should be noted that the changes in pH; seen in this study were relatively small compared with changes seen in hypoxic or ischemic brain in vivo, probably because of diffusion and dilution of metabolic acids into the medium rather than accumulation in solid tissue. As expected, cyanide and hypoxia caused acidification of the intracellular compartment in both astrocytes and brain slices. Iodoacetate caused intracellular alkalosis, presumably because of reduced glycolytic flux. The combination of both cyanide and iodoacetate produced an even more profound alkalinization, which may be due to the nearly complete conversion of phosphocreatine to ATP (which consumes protons 22 ) or from equilibration of intracellular and extracellular pH caused by massive cell injury.
Our results could mean that FBP may be most useful as a brain protectant when present at the time of insult.
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